BioVie: Cautiously Optimistic Ahead Of Phase 3 Alzheimer's Data Unblinding
Seeking Alpha,
Summary Blinded Phase 3 data of NE3107 in Alzheimer's appear to indicate robust cognitive and biomarker efficacy.
Summary Blinded Phase 3 data of NE3107 in Alzheimer's appear to indicate robust cognitive and biomarker efficacy.
Summary Cassava Sciences' results for mild Alzheimer's disease are better than placebo at 12 months but little better beyond…
March 16th, 2023 Senolytic drugs are those that selectively force senescent cells into programmed cell death.
Follow Summary Aricept, blarcamesine, simufilam, and panax ginseng by acting as acetylcholinesterase inhibitors and as indirect…